Clinical Trials Directory

Trials / Unknown

UnknownNCT01353846

Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA · Academic / Other
Sex
Female
Age
18 Years – 44 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the natural cycle (without any medication) with the well-established artificial cycle in an egg donation program.

Detailed description

Oocyte donation is an assisted reproduction technique well established. In patients with ovarian function, it is necessary to synchronize the cycle of the egg donor with the recipient, usually through endometrial preparation of the recipient by artificial cycle, by administering a GnRH agonist on day 21 of cycle and then administered increasing doses of estrogen therapy to achieve adequate endometrial thickness. The necessity of synchronization between donors and recipient, has made possible not routinely the natural cycle for oocyte donation. The investigators have recently introduced oocyte vitrification and it allows us to plan the egg donation in a different way. Now the investigators can previously cryopreserved donor oocytes and at the time that the investigators have a compatible receiver, then, plan the donation In this study it will be possible compare the results of oocyte donation cycles in terms of pregnancy rate, implantation and liveborn, depending on whether the recipient has made an artificial cycle of preparation endometrial or a natural cycle.

Conditions

Interventions

TypeNameDescription
OTHERobservation natural cycleThe patients natural reproductive cycle will be observed and compared to the second arm.
DRUGAgonist GnRH; estradiol Valerate; progesteroneMedications: Agonist GnRH Acetate Triptoreline and Acetate Triptorelina and Estradiol Valerate and Natural micronized progesterone, 400 mg/12 hours vaginal administration

Timeline

Start date
2011-05-01
Primary completion
2012-11-01
Completion
2012-11-01
First posted
2011-05-16
Last updated
2012-04-02

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01353846. Inclusion in this directory is not an endorsement.